Cyclacel Pharmaceuticals Inc (CYCC)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Cyclacel Pharmaceuticals Inc chart...

About the Company

cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.

CEO

Spiro Rombotis

Exchange

NASDAQ

Website

http://www.cyclacel.com/

$0M

Total Revenue

15

Employees

$32M

Market Capitalization

-1.35

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CYCC News

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

12d ago, source:

The R&D tax credit has been an important source of non-dilutive capital supporting Cyclacel’s programs. We appreciate this governmental support as we evaluate potential precision medicine approaches ...

Earnings week ahead: FedEx, Nike, XPeng, Tencent, General Mills and more

1d ago, source: Seeking Alpha on MSN

StoneCo (STNE), a provider of financial technology and software solutions, is scheduled to report its Q4 earnings after ...

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

5d ago, source:

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce ...

Bio-Path files to sell 1.15M shares of common stock, warrants

on MSN ago, source:

Bio-Path Holdings ( NASDAQ: BPTH) filed a prospectus related to the offer and sell of 1,152,073 shares of its common stock, warrants.

scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript

2d ago, source: InvestingChannel on MSN

Q4 2023 Earnings Call Transcript March 13, 2024 scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, ...

Before Buying Cyclo Therapeutics Inc (NASDAQ: CYTH) Stock, Read This First

5d ago, source:

Cyclo Therapeutics Inc (NASDAQ:CYTH) shares, rose in value, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.62. Actively observing the price movement ...

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript

4d ago, source: InvestingChannel on MSN

Q4 2023 Earnings Call Transcript March 12, 2024 MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc. isn't one of the 30 most popular stocks among ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...